Company / Current Assets
PROKIDNEY CORP. Current Assets History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$395.9M
FY2024
5-year range
$27.3M / $504.7M
FY2021-FY2024
Trend
+5.8%
vs FY2023
Sector context
#136 of 213
Health Care
What the data says
At $396M, PROKIDNEY CORP.'s current assets ranks #136 of 213 in the Health Care sector. Declined from $505M to $396M over the past 2 years.
Based on SEC 10-K filings.
$396M in FY2024 with a 3-year CAGR of +143.9%.
Declined from $505M to $396M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +143.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#136 of 213 in Health CareTop 64% of 213This company $395.9M Sector average $2.5B
▼
-84.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +143.9%, indicating consistent growth.
- In FY2024, current assets increased 5.8% year-over-year.
- Ranks #136 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $395.9M | +5.8% |
| FY2023 | $374.1M | -25.9% |
| FY2022 | $504.7M | +1750.8% |
| FY2021 | $27.3M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026